Steve Bryson PhD

Steve holds a PhD in Biochemistry from the Faculty of Medicine at the University of Toronto, Canada. He worked as a medical scientist for 18 years, within both industry and academia, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve recently stepped away from the lab and into science communications, where he’s helping make medical science information more accessible for everyone.

At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.

Articles by Steve Bryson PhD

Kira to Test KP-104 With KORU’s Infusion Device in SLE Phase 2 Trial

Kira Pharmaceuticals will test KP-104, an investigational therapy for a blood-clotting disorder associated with systemic lupus erythematosus (SLE),…

2 Machine Learning Models Found to Predict Hospitalization in SLE

Using clinical data collected over time, two machine learning computer models were found to accurately predict inpatient hospitalization due to…

GluN2A Protein Subunit in Nerve Cells May Be Treatment Target in SLE, Mouse Study Suggests

A specific protein subunit — called GluN2A — found in a critical nerve cell receptor is the target…

Acthar Gel Eases SLE Exacerbations and Symptoms, Study Reports

Treatment with Acthar Gel (repository corticotropin injection) may ease exacerbations and symptoms in people with systemic…

Endocannabinoid-based CLE Therapy Shows Promise in Early Tests

Early studies of an endocannabinoid-based treatment for cutaneous lupus erythematosus…

Lupus Patients Receiving More Quality Clinical Care Report Better Health Outcomes, Study Finds

People with systemic lupus erythematosus (SLE) who received more quality clinical care report lower disease…

Use of Glucocorticoids Linked to Organ Damage in SLE, Study Finds

Using glucocorticoids to treat inflammation in systemic lupus erythematosus (SLE) was associated…